CompletedNCT03309475

SocialMIND for Schizophrenia and Disorders With Psychotic Features; Psychotic Episode

It tested SocialMIND for Schizophrenia and Disorders With Psychotic Features; Psychotic Episode.

SchizophreniaBehavioralFrom 18 Years to 45 Years

The study in practice

Understand this study

Listed age limits: 18 years to 45 years.

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study start dateStarted: September 1, 2018

Recruitment status: Completed
Enrollment listed in the registry: 59
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Sponsor type: Hospital / academic medical center
Study type: Behavioral
Intervention type: Psychotherapy / behavioral intervention, Medication / drug
Study phase: Not clearly listed
Locations: Spain
Age range: From 18 Years to 45 Years
Official registry ID: NCT03309475
Official title: Mindfulness-based Social Cognition Group Training (SocialMIND) Versus Psychoeducational Multicomponent Intervention in Patients With a First Episode of Psychosis (AGES-Mind Study): A Randomized Controlled Trial

Completed

Madrid

FAQ

Who is behind this study?

The study sponsor is Instituto de Investigación Hospital Universitario La Paz, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Psychotropic treatment.

Who was this study for?

Listed age limits: 18 years to 45 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.